See All Slides - tctmd.com

Slides

Presentation TCT 2016

FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways

Presenter: Nicole Ibrahim, Martin B. Leon, Jaime Raben

November 01, 2016

Presentation TCT 2016

Pulmonary Artery Denervation for Chronic Pulmonary Hypertension I: Experimental Insights

Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Alex M. K. Rothman

November 01, 2016

Presentation TCT 2016

My Best Antegrade Case(s) of the Last Year

Presenter: Colm Hanratty, Paul Hsien-Li Kao, Jianfang Luo

November 01, 2016

Presentation TCT 2016

Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic AF Patient Who Requires PCI

Presenter: David P. Faxon, C. Michael Gibson, Deepak L. Bhatt

November 01, 2016

Presentation TCT 2016

Venous Access Specifics: Puncture, Sheath Introduction, Traversing the IVC, and Puncture Site Closure

Presenter: Maurice Buchbinder, Saibal Kar, Sameer Gafoor

November 01, 2016

Presentation TCT 2016

Interatrial Shunts: Theoretical Basis and Unanswered Questions

Presenter: Josep Rodés-Cabau, Nir Uriel, Daniel Burkhoff

November 01, 2016

Presentation TCT 2016

Lotus and EDGE: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., Ted Feldman

November 01, 2016

Presentation TCT 2016

Metallic Versus Polymeric BRS: Differences In Mechanical Properties and Preclinical Bench Testing

Presenter: Stephen G. Ellis, Patrick W. Serruys, Ron Waksman

November 01, 2016

Presentation TCT 2016

Atrial Septostomy for Chronic Pulmonary Hypertension

Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Gagan D Singh

November 01, 2016

Presentation TCT 2016

When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy?

Presenter: David P. Faxon, C. Michael Gibson, Roxana Mehran

November 01, 2016

Advertisement

Slides

FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways

Pulmonary Artery Denervation for Chronic Pulmonary Hypertension I: Experimental Insights

My Best Antegrade Case(s) of the Last Year

Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic AF Patient Who Requires PCI

Venous Access Specifics: Puncture, Sheath Introduction, Traversing the IVC, and Puncture Site Closure

Interatrial Shunts: Theoretical Basis and Unanswered Questions

Lotus and EDGE: Design Features, Special Attributes, and Clinical Trial Program

Metallic Versus Polymeric BRS: Differences In Mechanical Properties and Preclinical Bench Testing

Atrial Septostomy for Chronic Pulmonary Hypertension

When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content